CTLA4 and graft versus host disease: Literature Review of Haploidentical Hematopoietic Cell Transplant (HCT) Utilizing Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4-Ig) Blockade for Graft-Versus-Host-Disease (GVHD) Prophylaxis.